Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Targeting specific cell interactions may help treat skin fibrosis.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Targeting TRP channels may help reduce excessive scarring.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Targeting CD169+ skin macrophages may help treat psoriasis.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.